Vu Minh Quan

Vu Minh Quan

Auto-generated profile, based on publicly available information

Vu Minh Quan

Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2008 in AIDS Care
Verified
Journal Article
Closed access
VQVu Minh Quan
Vu Minh Quan
VGVivian F. Go
Vivian F. Go
LNLe Van Nam
Le Van Nam
ABAnna Bergenstrom
Anna Bergenstrom
NTNguyen Phuong Thuoc
Nguyen Phuong Thuoc
DCDavid D. Celentano
David D. Celentano
Injection drug use (IDU) and HIV infection are important public health problems in Vietnam. The IDU population increased 70% from 2000 to 2004 and is disproportionately affected by HIV and AIDS -- the country's second leading cause of death. Hepatitis B virus (HBV) and hepatitis C virus (HCV) share transmission routes with HIV and cause serious medical consequences. This study aimed to determine risk factors for acquisition of HIV, HBV, and HCV infections among IDUs in a northern province. We conducted a matched case-control study among active IDUs aged 18-45 who participated in a community-based survey (30-minute interview and serologic testing). Each HIV-infected IDU (case) was matched with one HIV-uninfected IDU (control) by age, sex (males only), and study site (128 pairs). Similar procedures were used for HBV infection (50 pairs) and HCV infection (65 pairs). Conditional logistic regression models were fit to identify risk factors for each infection. Among 309 surveyed IDUs, the HIV, HBV, and HCV prevalence was 42.4%, 80.9%, and 74.1%, respectively. Only 11.0% reported having been vaccinated against hepatitis B. While 13.3% of the IDUs reported sharing needles (past six months), 63.8% engaged in indirect sharing practices (past six months), including sharing drug solutions, containers, rinse water, and frontloading drugs. In multivariable models, sharing drugs through frontloading was significantly associated with HIV infection (odds ratio [OR]=2.8), HBV infection (OR=3.8), and HCV infection (OR=4.6). We report an unrecognized association between sharing drugs through frontloading and higher rates of HIV, HBV and HCV infections among male IDUs in Vietnam. This finding may have important implications for bloodborne viral prevention for IDUs in Vietnam.

4 November 2010 in Addiction
Verified
Journal Article
Closed access
PDF file
VQVu Minh Quan
Vu Minh Quan
NMNguyen Le Minh
Nguyen Le Minh
THTran Viet Ha
Tran Viet Ha
NNNguyen Phuong Ngoc
Nguyen Phuong Ngoc
PVPham The Vu
Pham The Vu
VGVivian F. Go
Vivian F. Go

22 January 2007 in Addiction
Verified
Journal Article
Closed access
PDF file
VQVu Minh Quan
Vu Minh Quan
TVTasanai Vongchak
Tasanai Vongchak
JJJaroon Jittiwutikarn
Jaroon Jittiwutikarn
SKSurinda Kawichai
Surinda Kawichai
NSNamtip Srirak
Namtip Srirak
DCDavid D. Celentano
David D. Celentano

4 November 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
RFR. J. Fredericksen
R. J. Fredericksen
BWB. M. Whitney
B. M. Whitney
ETE. Trejo
E. Trejo
RNR. M. Nance
R. M. Nance
EFE. Fitzsimmons
E. Fitzsimmons
JDJ. A. C. Delaney
J. A. C. Delaney
Background: We analyzed the association between substance use (SU) and condomless sex (CS) among HIV-negative adults reporting heterosexual sex in the Seek, Test, Treat, and Retain (STTR) consortium. We describe the impact of SU as well as person/partner and context-related factors on CS, identifying combinations of factors that indicate the highest likelihood of CS. Methods: We analyzed data from four US-based STTR studies to examine the effect of SU on CS using two SU exposures: 1) recent SU (within 3 months) and 2) SU before/during sex. Behavioral data were collected via 1:1 or self-administered computerized interviews. Adjusted individual-study, multivariable relative risk regression was used to examine the relationship between CS and SU. We also examined interactions with type of sex and partner HIV status. Pooled effect estimates were calculated using traditional fixed-effects meta-analysis. We analyzed data for recent SU (n = 6781; 82% men, median age = 33 years) and SU before/during sex (n = 2915; 69% men, median age = 40 years). Results: For both exposure classifications, any SU other than cannabis increased the likelihood of CS relative to non-SU (8–16%, p-values< 0.001). In the recent SU group, however, polysubstance use did not increase the likelihood of CS compared to single-substance use. Cannabis use did not increase the likelihood of CS, regardless of frequency of use. Type of sex was associated with CS; those reporting vaginal and anal sex had a higher likelihood of CS compared to vaginal sex only for both exposure classifications (18–21%, p < 0.001). Recent SU increased likelihood of CS among those reporting vaginal sex only (9–10%, p < 0.001); results were similar for those reporting vaginal and anal sex (5–8%, p < 0.01). SU before/during sex increased the likelihood of CS among those reporting vaginal sex only (20%; p < 0.001) and among those reporting vaginal and anal sex (7%; p = 0.002). Single- and poly-SU before/during sex increased the likelihood of CS for those with exclusively HIV-negative partners (7–8%, p ≤ 0.02), and for those reporting HIV-negative and HIV-status unknown partners (9–13%, p ≤ 0.03). Conclusion: Except for cannabis, any SU increased the likelihood of CS. CS was associated with having perceived HIV-negative partners and with having had both anal/vaginal sex.

1 December 2010 in Journal of Addiction Medicine
Verified
Journal Article
Closed access
VQVu Minh Quan
Vu Minh Quan
AAApinun Aramrattana
Apinun Aramrattana
TVTasanai Vongchak
Tasanai Vongchak
CLCarl Latkin
Carl Latkin
DDDeborah Donnell
Deborah Donnell
DCDavid D. Dsc Celentano
David D. Dsc Celentano
Objectives: To measure mortality rates and assess predictors of all-cause mortality in a cohort of Thai injection drug users (IDUs) who were enrolled and followed up from 2004 through 2006. Methods: In this prospective cohort study, we enrolled 314 community-dwelling IDUs (95% being men; 42% of ethnic minority; median age, 29 years [range, 18–69 years]) and followed up them at 6-month intervals. Mortality rates were calculated based on person-years of follow-up. Marginal Cox proportional hazards models for clustered data were constructed to determine the factors associated with all-cause mortality. Findings: During 445.7 person-years of follow-up, 17 of 314 (5.4%) IDUs died. The all-cause mortality rate was 3.8 per 100 person-years (95% confidence interval [CI] = 2.2–6.1). The standardized mortality ratio was 5.8 (95% CI = 3.5–9.1). The mortality rate among HIV-positive IDUs was 13.4 per 100 person-years (95% CI = 5.4–27.6). In a marginal Cox proportional-hazards model for clustered data, the excess mortality was associated with HIV-positivity (hazard ratio [HR] = 7.0, 95% CI = 2.8–17.6), benzodiazepine use (HR = 3.1, 95% CI = 1.1–9.4), and excessive alcohol consumption at enrollment (HR = 3.5, 95% CI = 1.3–9.1). Conclusions: The all-cause mortality among the drug injectors is high. The increased mortality was associated with HIV infection, benzodiazepine use, and excessive alcohol consumption.